| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2598897A1 Fungicidal pyrazine derivatives |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1692133A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | CN1823113A Diamine having quinoxaline unit, polyimide precursor, polyimide and use thereof |
| 08/23/2006 | CN1821231A Process for preparing deoxy fructosazine |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2006084688A1 HIV protease inhibitors |
| 08/17/2006 | US20060183909 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 08/17/2006 | US20060183903 Reacting 4-(alpha-(p-chlorophenyl)benzyl)-1-leaving group-alkylpiperazine with protected 1-hydroxy-1-(4-(p-hydroxyphenyl)-3-butynyl)urea to form 1-(4-(p-(4-(alpha-(p-chlorophenyl)benzyl)-1-piperazin-1-ylalkyl)phenyl)-3-butynyl)-1-hydroxyurea; preparation of intermediates |
| 08/17/2006 | CA2594395A1 Hiv protease inhibitors |
| 08/17/2006 | CA2592776A1 Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820000A A method for the preparation of enantiomerically pure mirtazapine |
| 08/16/2006 | CN1817881A Production of stilsarin coarse products |
| 08/16/2006 | CN1817864A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178370 Ketopiperazine derivatives as bradykinin antagonists |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1687856A1 Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1687281A1 Synthesis of 2-chloro-3,6-dialkyl pyrazines |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1537114B1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1816337A Naphthalene-containing melanocortin receptor-specific small molecule |
| 08/09/2006 | CN1268616C Method for producing Carbadox growth promoter for livestock and brids |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087416 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET) |
| 08/08/2006 | CA2238619C Preparation of bis(fluoroalkylenesulfonyl)imides and (fluoroalkylsulfonyl) (fluorosulfonyl)imides |
| 08/03/2006 | WO2006079478A1 2-phenylquinoxalines as inhibitors for mpp1 |
| 08/03/2006 | WO2005095361A8 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 08/03/2006 | US20060173015 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | CN1812970A Process for producing nitrogenous heterocyclic compound |
| 08/02/2006 | CN1812963A N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006078619A1 Insecticidal heterocyclic 1,4-disubstituted benzene n-oxides |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006076797A1 Cathepsin k inhibitors and atherosclerosis |
| 07/27/2006 | WO2006050128A3 Heterocyclical chromophore architectures |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/26/2006 | EP1683523A1 2-Phenylquinoxalines as inhibitors for MPP1 |
| 07/26/2006 | EP1682508A1 Phenyl derivatives as ppar agonists |
| 07/26/2006 | CN1809554A 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 07/26/2006 | CN1809530A Haloalkyl containing compounds as cysteine protease inhibitors |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/25/2006 | US7081346 Contacting complex comprising receptor and quinoxaline derivative ligand bound thereto with test compound, yielding a receptor-test compound complex and free quinoxaline derivative and measuring amount of free quinoxaline derivative generated |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006075159A1 Anti-bacterial compounds |
| 07/20/2006 | US20060161020 2-(Benzoylamino-3-phenylpropylamino]acetamide derivatives prevent the formation of insoluble A beta |
| 07/20/2006 | US20060161003 Reacting 2-methylpiperazine and benzyl chlorocarbonate or di-tert-butyl dicarbonate in an organic alcohol solvent with a water content of <15 wt % in the presence of a nitrogen-containing compound; stereoisomer; resolution by acid salt formation; simplification; efficiency |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160825 1-(5-Benzenesulfonyl-indan-1-yl)-piperazine, used as selective serotonin receptor antagonists for treatment of nervous system and gastrointestinal disorders |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/19/2006 | EP1680409A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 07/19/2006 | EP1097927B1 Cyanoiminoquinoxaline derivatives |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803779A Method for purifying polyhydroxy alkyl pyrazine compound from browning reaction liquor |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |